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Edited by Hans EklundAbstract The conversion of adenine and guanine nucleoside tri-
phosphates to cAMP and cGMP is carried out by nucleotide
cyclases, which vary in their primary sequence and are therefore
grouped into six classes. The class III enzymes encompass all
eukaryotic adenylyl and guanylyl cyclase, and several bacterial
and archaebacterial cyclases. Mycobacterial nucleotide cyclases
show distinct biochemical properties and domain fusions, and we
review here biochemical and structural studies on these enzymes
from Mycobacterium tuberculosis and related bacteria. We also
present an in silico analysis of nucleotide cyclases found in com-
pletely sequenced mycobacterial genomes. It is clear that this
group of enzymes demonstrates the tinkering in the class III cy-
clase domain during evolution, involving subtle structural
changes that retain the overall catalytic function and ﬁne tune
their activities.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Nucleotide cyclases, the enzymes that convert NTP’s into
the respective 3 0,5 0-cyclic nucleoside monophosphates, are a
large group of proteins in which the function of synthesizing
these second messengers has evolved through convergent evo-
lution [1]. Nucleotide cyclases synthesize cAMP in a metal-
dependent manner, and can be grouped into six classes based
on their primary amino acid sequences. Classes I, II, V and
VI are exclusive to bacteria, while enzymes from class IV have
thermostable properties and are found in archaebacteria as
well [1,2]. Class III nucleotide cyclases, which includes all
known guanylyl cyclases, have the widest phyletic distribution,
being present in all eukaryotes as well as in several bacteria
and archaebacteria [3].
Class III adenylyl and guanylyl cyclases are proteins with
a central four stranded anti-parallel b-sheet (Fig. 1) structur-
ally similar to the ‘palm’ domain of DNA polymerases, and
a-helices on either side [4]. Residues important for catalytic
activity were identiﬁed based on mutational and structural
analyses of mammalian enzymes. Evidence from crystal*Corresponding authors. Fax: +91 80 23600999.
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doi:10.1016/j.febslet.2006.05.034structures of mammalian adenylyl cyclases indicate that
two cyclase domains form a head-to-tail dimer and generate
the active dimeric enzyme (Fig. 1). Catalytic activity requires
the presence of conserved metal, substrate (either ATP or
GTP) binding residues and transition-state stabilizing resi-
dues. These are often present in a single polypeptide chain
giving rise to the family of mammalian receptor guanylyl
cyclases and homodimeric bacterial nucleotide cyclases
[5,6]. These cyclases are therefore composed of identical sub-
units and contain two perfectly symmetric catalytic sites. If
the subunits are not identical, the dimeric enzyme has
pseudosymmetric sites and usually only one of the two sites
is catalytically competent (Fig. 1). For example, in the
12-transmembrane adenylyl cyclases, two tandem class III
cyclase domains are found in a single polypeptide chain
(called C1 and C2 by convention) [5]. The C1 domain pro-
vides residues that contribute to metal-binding while the C2
domain contains residues that confer nucleotide (substrate)
speciﬁcity (lysine–aspartate pair in adenylyl cyclases or a
glutamate–cysteine pair in guanylyl cyclases). The transi-
tion-state stabilizing asparagine–arginine pair of residues
are also present in the C2 domain [5]. Thus, based on their
functionalities in the mammalian membrane-bound adenylyl
cyclases, cyclase domains have been classiﬁed as C1-like or
C2-like [5]. The a and b subunits of eukaryotic soluble gua-
nylyl cyclases are also functionally analogous to the C1 and
C2 domains.
Bacterial class III adenylyl cyclases have diversiﬁed by
means of various domains fusions, as well as variations in se-
quence in the catalytic cyclase domain [3,6,7]. In recent years,
the adenylyl cyclases present in cyanobacteria and mycobac-
teria, have been well studied [6]. Among the adenylyl cyclases
in M. tuberculosis, studies on Rv1625c highlighted a new role
for substrate specifying residues in the maintenance of the
oligomeric state of cyclases [8–11], Rv1264 revealed a mecha-
nism for pH sensing [12,13], Rv1900c suggested that asym-
metric heterodimeric cyclases could have evolved from
homodimeric bacterial cyclases [14], Rv1647 showed that
divergent adenylyl cyclases can have a predominantly hydro-
phobic dimeric interface [15] and Rv0386 could have a novel
mechanism for substrate selectivity [16]. Given the recent
explosion of information on mycobacterial cyclases, we re-
view here the biochemical and structural aspects of these en-
zymes and comment on the insights provided by these
enzymes on our understanding of class III nucleotide cyclases
in general.blished by Elsevier B.V. All rights reserved.
Fig. 1. Structure and schematic representation of class III cyclases. (A) Heterodimeric class III cyclases, e.g. 12- or 22-transmembrane adenylyl or
guanylyl cyclases. The crystal structure of the mammalian adenylyl cyclase C1 and C2 domains showing forskolin and a P-site inhibitor is shown
(PDB ID 1cjv). The right panel shows a schematic representation of the heterodimer with one active site (dotted circle; occupied by the P-site
inhibitor in 1cjv) and a pseudosymmetric inactive site (dotted square; occupied by forskolin in 1cjv). Notice the overall structural similarity of the C1
and C2 chains and their head-to-tail dimerization. (B) Homodimeric class III cyclases, e.g. bacterial adenylyl cyclases and receptor guanylyl cyclases.
Crystal structure of a Spirulina adenylyl cyclase is shown with two active sites occupied by ATP analogues (PDB ID 1wc5). The right panel shows the
schematic homodimer. Metals are shown as spheres. Notice the overall similarities in the subunits of the homodimeric cyclase in B and the C1 and C2
chains in A.
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The genome of M. tuberculosis H37Rv encodes 16 class III
cyclases while the CDC1551 strain has 17 cyclases [17–19]. Sev-
eral of these gene products were earlier annotated as ‘‘putative
cyclases’’ or ‘‘conserved hypotheticals’’, but have now been
characterized biochemically and structurally. All the identiﬁed
mycobacterial class III cyclases are listed in Table 1 and a mul-
tiple sequence alignment of the cyclase domains found in the
cyclase-like genes in M. tuberculosis is shown in Fig. 2.
Biochemically characterized cyclases from mycobacteria re-
tain similar catalytic properties to the mammalian enzymes,
in terms of the requirement for divalent cations, and dimeriza-
tion as a prerequisite to generate the catalytic site. However,
very precise allosteric regulation of the catalytic activities of
some of the mycobacterial enzymes is evident, and Hill coeﬃ-
cients vary from 1 to as high as 4 [8,9]. A summary of the bio-
chemical and structural features of the characterized enzymes
is provided here. As described below, distinct features of indi-
vidual enzymes highlight the lack of generalities and common
properties in these proteins.2.1. The ﬁrst characterized adenylyl cyclase from mycobacteria:
Rv1625c
Rv1625c was the ﬁrst adenylyl cyclase to be characterized
fromM. tuberculosis H37Rv, perhaps because the catalytic do-
main of this protein has the highest sequence similarity with
the mammalian enzymes [8,10]. Rv1625c is a six-transmem-
brane protein with a single class III cyclase domain (Table 1)
and therefore topologically equivalent to half of the 12-trans-
membrane mammalian adenylyl cyclases. The puriﬁed cata-
lytic domain of Rv1625c has high adenylyl cyclase activity,
which is increased if the two catalytic domains are artiﬁcially
linked by a ﬂexible linker, suggesting that forceful dimerization
stabilizes the enzyme [8].
Mutation of the metal-binding (D256 and D300; Fig. 2),
substrate specifying (K296 and D365) and transition state sta-
bilizing (R376) residues to alanine, led to signiﬁcant decreases
in adenylyl cyclase activity of the mutant Rv1625c proteins,
indicating the conservation of the biochemical mechanism
for cyclization in nucleotide cyclases [8]. Like the mammalian
heterodimeric adenylyl cyclases, mixtures of artiﬁcial C1-like
(K296A, D365A and R376A) and C2-like (D256A and
Table 1
Distribution and domain compositions of class III cyclases in mycobacteria with completely sequenced genomes
Domain compositions M.avi M.lep M.mar M.sme M.tub
MAP1357 ML1399 MM0157 MSMEG3786 Rv1264
MAP2507c MM0935 MSMEG4282 Rv1647
MM2454 MSMEG5003 Rv2212
MM3257
MM4173
MAP2672 MM3042 MSMEG0536 Rv0891c
MSMEG3253 Rv1120c
Rv1359
MM0286 MSMEG4472 Rv1900c
MM3505
MAP3844
ML2341
MM5257
MM3043
ML1753 MM0123 Rv0386
MM2962 Rv1358
Rv2488c
MM3522 MSMEG0218
MM5254
MM1414
MM4340
MAP1318c MM0666 Rv1625c
MM2428
MAP1279c
MAP2250c MM3755 MSMEG3579 Rv2435c
MM3757
MM2550
MAP0426c ML0201 MM3795 MSMEG4909 Rv1318c
MAP2440 MM4078 MSMEG6117 Rv1319c
MAP2695c MM4079 Rv1320c
MM4080 Rv3645
MM4120
MM4370
MM4438
MM5137
MAP4266 MM3640
MM0730
MAP2079
Total 12 4 31 10 16
Class III nucleotide cyclases were identiﬁed using PSI-BLAST and HMM approaches as described earlier [3]. Original genome annotations have been
listed and the names of organisms have been abbreviated as follows: M.avi – M. avium subsp. paratuberculosis, M.lep – M. leprae, M.mar – M.
marinum, M.sme – M. smegmatis, M.tub – M. tuberculosis [18,42,43]. The genes in M. tuberculosis strain CDC1551 and M. bovis are identical or
highly similar to those in M. tuberculosis strain H37Rv, have not been enlisted as they have been discussed elsewhere earlier [19]. Domain
compositions were identiﬁed using the Conserved Domain Database (http://www.ncbi.nlm.nih.gov/Structure/cdd/cdd.shtml) and transmembrane
helices were identiﬁed using the TMHMM programme (TMHMM website http://www.cbs.dtu.dk/services/TMHMM/). Representative schematic
domain compositions are shown where vertical lines represent transmembrane helices and other abbreviations are as follows: ABH – ab – hydrolase;
ACA – adenylyl cyclase associated; ATPase – AAA+ type ATPase; B – bacterial transcription activating domain; Cyc – class III cyclase domain;
DUF – domain of unknown function; H – HAMP domain; HTH – helix-turn-helix DNA-binding domain; R – two-component receiver domain;
Tr – transcription regulatory, C-terminal domain; YSH – a domain containing conserved cysteine residues probably involved in binding metals.
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Fig. 2. Multiple sequence alignment of the cyclase domains ofM. tuberculosis class III nucleotide cyclases. Proteins were aligned using the MUSCLE
alignment programme [44], and the regions encompassing the cyclase domains are shown (amino acid positions provided after names). ﬂ – metal bind
residues;  – substrate specifying residues; $ – transition state stabilizing residues. * represents residues that are conserved in all sequences.
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tive enzyme suggesting that a catalytic mechanism similar to
the heterodimeric enzymes can be engineered in bacterial
homodimeric enzymes [8]. Physical association between
Rv1625c mutants to form heterodimers was also demonstrated
with the use of GST-pull down experiments [11]. Interestingly,
the C2-like Rv1625c mutant protein (D300A) could heterodi-
merize and reconstitute activity with the Paramaecium gua-
nylyl cyclase C1-like domain (the second cyclase domain in
this guanylyl cyclase, but functionally a C1 domain) [20]. How-
ever, Rv1625c mutants could not reconstitute activity with C1
or C2 domains of the mammalian adenylyl cyclase isoforms
[20], or with Rv1647 as described below.
Despite an overall sequence similarity to the guanylyl cyc-
lases, substitutions in either one more of the substrate specify-
ing residues in Rv1625c (i.e. K296E, D365C and F363R
mutations) did not result in a gain of guanylyl cyclase activity,
but led to severely compromised adenylyl cyclase activity. This
appeared to be due to altered oligomeric status of the mutant
proteins [9]. A protein containing all three substrate specifying
residue mutations (K296E/F363R/D365C) was largely mono-
meric, had neither adenylyl cyclase or guanylyl cyclase activity,
and was unable to heterodimerize with the wild-type protein
[9]. A structural basis for these observations was subsequently
provided. While the overall structure of the mutant Rv1625c
closely resembled mammalian and other bacterial adenylyl
cyclases (Fig. 3A), signiﬁcant movements of critical loops con-
taining the metal-binding as well as the substrate specifying
residues were seen [11]. Consequently, the modelled dimer of
the crystallized protein revealed signiﬁcant interfacial clashes
which precluded dimerization, providing an explanation forthe monomeric nature of the K296E/F363R/D365C protein
and its lack of activity [11].
All these studies indicate the uniqueness of the ATP-binding
pocket of Rv1625c, wherein mutation of residues involved in
substrate speciﬁcity could either alter the oligomeric state of
the enzyme, or aﬀect activity by perhaps modifying substrate
positioning in the active site cleft. This could also perhaps ac-
count for the lack of inhibition of Rv1625c by P-site ATP ana-
logues [9,21] which are known to be potent inhibitors of the
mammalian adenylyl cyclases.
The full length Rv1625c protein has been puriﬁed to homo-
geneity following overexpression in Escherichia coli and has
also been shown to be catalytically active when expressed in
mammalian cells [8]. An early report showed that mutation
of two arginine residues in the extreme N-terminal region
(the R43A/R44G mutant), preceding the ﬁrst transmembrane
helix, severely compromised adenylyl activity of the full length
Rv1625c protein, indicating the role of the extreme N-termi-
nus, and perhaps the transmembrane domains, in regulating
the catalytic activity [10].
2.2. An adenylyl cyclase regulated by pH: Rv1264
The Rv1264 adenylyl cyclase has closely related proteins
found in the genomes of M. bovis, M. avium, M. marinum,
and M. smegmatis (Table 1) and in actinobacteria such as
Brevibacterium and Streptomyces [19]. The ﬁrst 200 amino
acid region of Rv1264 is auto-inhibitory, since the puriﬁed
holoenzyme had a lower speciﬁc activity as compared to the
puriﬁed catalytic domain protein alone [12]. However, this
puriﬁed N-terminal domain did not aﬀect the activity of cata-
lytic domain in trans, indicating that the N-terminal region of
Fig. 3. Structures of mycobacterial adenylyl cyclases. (A) Rv1625c K296E/F363R/D365C mutant crystallized as a monomer (PDB ID 1yk9) has
signiﬁcant overall structural similarity to other class III cyclases. (B) Rv1264 was crystallized in the active (PDB ID 1y11) and inactive conformations
(PDB ID 1y10). The N-terminal domain is shown separately in the upper panels. The aN10 regions that change conformation are highlighted in red
and cyan to bring out diﬀerences in the conformations in the two states. Cyclase domains shown in the lower panel sit on top of the N-terminal
domains and have been shown separately for clarity. (C) The homodimer of Rv1900c in the active (bound to an ATP analogue; PDB ID 1ybu) shows
asymmetry in the two nucleotide binding sites despite complete sequence identity in the two subunits. Thus, only one of the two substrate binding
sites has the ATP analogue and is presumably active. The metal atom is shown as a sphere. Notice the similarity in the overall structure of the active
form of the Rv1264 cyclase domain with that of Rv1625c in A, Rv1900c in C and the cyclases shown in Fig. 1.
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enzyme [12].
A Streptomyces strain lacking the Rv1264-like cyclase is un-
able to execute an apparently cAMP and acid pH-dependent
diﬀerentiation pathway, which suggested that the activity of
Rv1264 could be regulated by pH [22]. Indeed, the Rv1264
holoenzyme shows higher adenylyl cyclase activity at acidic
pH (pH 6.0) [13]. In contrast, the puriﬁed cyclase domain
showed similar activities at both pH 5.5 and pH 8.0. The full
length Rv1264 crystal structure is the ﬁrst adenylyl cyclase
holoenzyme structure to be solved [13], and revealed the con-
formational changes that are responsible for the pH-dependent
switch between the active and inactive states (Fig. 3B). In the
active conformation, the linker between the N-terminus and
the catalytic domain (aN10 switch) is a random coil that con-
nects the two catalytic domains loosely (Fig. 3B). The same re-
gion attains a helical conformation in the inactive state of the
enzyme and the catalytic domains are wrenched apart
(Fig. 3B). Additionally, the phosphate binding P-loop of region
Rv1264 has an a-helical conformation in the active state and at-
tains a random coiled conformation in the inactive state [13].
The N-terminal domain of Rv1264, contains long a-helices
that cross each other, such that the N-terminal domain of
one protomer makes contacts with the cyclase domain of the
other protomer (Fig. 3B). This regulates the head-to-tail dimer-
ization of the cyclase domain [13]. The introduction of proline
residues in the aN10 region, that are incapable of forming a-
helices, abrogated pH sensitivity of Rv1264 [13]. Thus, pH
sensing is not a property of any single amino acid in Rv1264
but a property of a network of interactions between the N-ter-minal and cyclase domains. Importantly, the substrate binding
lysine (K261) and aspartate (D312) residues in Rv1264 also
participate in this network, being held far away from their ac-
tive-state position when the pH is not optimal [13].
2.3. Adenylyl cyclases with HAMP domains: Rv1318c,
Rv1319c, Rv1320c, Rv3645
HAMP (common to histidine kinases, adenylyl cyclases,
methyl-accepting chemotaxis proteins and phosphatases) do-
mains (50 amino acids) contain two amphipathic helices that
are thought to associate with the lower leaﬂet of the lipid bi-
layer [23]. Mycobacterial adenylyl cyclases with HAMP do-
mains (Rv1318c, Rv1319c, Rv1320c, Rv3645) have six
transmembrane regions, followed by the HAMP domain and
a C-terminal adenylyl cyclase domain (Table 1). The
Rv1318c gene-family has another member with identical do-
main composition in the M. tuberculosis strain CDC1551, tak-
ing up its tally of cyclases to one more than that in strain
H37Rv [17,19]. The HAMP domain of Rv3645 activates it
while in Rv1319c, the domain inhibits adenylyl cyclase activity
[24]. Importantly, the Rv1318c-family proteins have higher se-
quence similarity in their cyclase domains (Fig. 2) as compared
to the N-terminal membrane anchoring regions and the ex-
treme C-termini. Thus, the sequence correlates of the regula-
tory eﬀect of HAMP domains (whether stimulatory or
inhibitory) on cyclases remain to be identiﬁed.
The second substrate specifying residue in this group of cyc-
lases is threonine (Fig. 2). This classiﬁes them as ‘bicarbonate
sensing’, in a manner suggested for adenylyl cyclases with the
lysine–threonine combination of substrate specifying residues
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tion has been demonstrated only for the puriﬁed Rv1319c cat-
alytic domain [25], but the eﬀect on the Km of the enzyme in
the presence of bicarbonate has not been reported. In related
proteins, the presence of bicarbonate increased the apparent
Vmax, with either no change (or an even an increase) in the
apparent Km for ATP [26]. In the case of the cyanobacterial
adenylyl cyclase, the structural basis for the activation of cy-
clase activity by carbonate was shown to be by a closure of
the active site [27].2.4. Divergent cyclases: Rv1647 and ML1399
The Rv1647 adenylyl cyclase has a cyclase domain that is
more closely related to fungal and protist cyclases and contains
an N-terminal region (100 amino acids) which does not bear
sequence similarity to domains identiﬁed in current databases
(Table 1). Despite the lack of any predicted transmembrane re-
gions, Rv1647 was found to be localized to the particulate (cell-
wall and plasma membrane) as well as the cytosolic fractions in
M. tuberculosis as judged byWestern blotting analysis [15]. The
puriﬁed catalytic domain of Rv1647 is a highly active adenylyl
cyclase with pH optima in the alkaline pH range. Interestingly,
Rv1647 is slightly (1.5–2-fold) activated by detergents or high
ionic concentrations (500 mMNaCl) [15]. This suggests that the
dimerization in Rv1647 may be dependent to a large extent on
hydrophobic interactions. Artiﬁcially generated C1-like (sub-
strate specifying residues mutated; K187E/D241C; Fig. 2) and
C2-like (ﬁrst metal-binding residue mutated; D147A) mutants
of Rv1647 were barely active on their own but reconstituted
high adenylyl cyclase activity as mixtures [15]. However, hetero-
dimerization with a C2-like mutant of Rv1625c did not occur,
perhaps because of the distinct biochemical properties of the
two enzymes [15]. Mutation of substrate specifying residues in
Rv1647 to those present in guanylyl cyclases (K187E and
D241C singly or together) did not lead to a gain in guanylyl cy-
clase activity. However, in contrast to Rv1625c, these mutants
did not have an altered oligomeric state [15].
The Rv1647 orthologue from M. leprae, ML1399, has also
been cloned, expressed, puriﬁed and shown to have adenylyl
cyclase activity [15]. Despite being ﬂanked by pseudogenes,
ML1399 has been retained as a functional gene in M. leprae,
as judged by Western blot analysis to monitor expression of
ML1399 in cell-free extracts [15]. This suggests that Rv1647
and its orthologues could play some as yet unidentiﬁed role
in the physiology of mycobacteria.2.5. The structurally asymmetric Rv1900c
Rv1900c has an N-terminal ab-hydrolase domain (300
amino acids) followed by the cyclase domain (Table 1), but
the ab-hydrolase domain showed no hydrolytic activity against
several compounds that were tested, perhaps due to the lack of
catalytic residues [14]. Whether this domain is able to catalyze
the hydrolysis of as yet unidentiﬁed substrates remains an open
question.
The crystal structure of the cyclase domain of Rv1900c in
the absence and presence of an ATP analogue provided a
glimpse of the evolution of heterodimeric cyclases (containing
single catalytic centres) from homodimeric enzymes [14]. The
active form (crystallized in the presence of an ATP analogue)
was found to contain the metal and the nucleotide only at
one of the two active sites (Fig. 3C). Closure of the active sitepocket containing the nucleotide was achieved by a movement
in the P-loop. The critical catalytic residues in the ‘empty’ site
were found to form a hydrogen bonded network that presum-
ably kept this site in an inactive conformation [14]. The
homodimer of the Rv1900c cyclase domain therefore has an
intrinsic asymmetry, i.e. the two active sites, though exactly
identical in sequence, were structurally distinct [14].
Interestingly, the ATP analogue was not found to make any
contacts with the substrate specifying residues (N342 and
D395; Fig. 2) in Rv1900c, which is unlike what has been ob-
served in the structures of mammalian enzymes and Rv1264,
where the lysine–aspartate pair forms bonds with the purine
ring of adenosine. In agreement with this, the mutation of
N342 did not aﬀect adenylyl cyclase activity in Rv1900c, a
property that is so far unique to it [14]. Additionally, the tran-
sition-state stabilizing residue H402 (which replaces the usually
found asparagine at this position) was also not found to be
critical for maintaining adenylyl cyclase activity [14].2.6. A dual-speciﬁc nucleotide cyclase: Rv0386
Rv0386 is the ﬁrst biochemically characterized representa-
tive of the family of putative DNA-binding domain-containing
cyclases (Table 1) in mycobacteria [16]. Interestingly, Rv0386
shows both adenylyl and a guanylyl cyclase side-activity that
is 20% of its adenylyl cyclase activity [16]. This was perhaps
due to the presence of a non-canonical glutamine–asparagine
pair of substrate specifying residues in Rv0386 (Fig. 2). Muta-
tion of these residues to the canonical lysine–aspartate (the
Q57K/N106D mutant; Fig. 2) or alanines abolished activity
[16]. Thus, in contrast to Rv1900c, in Rv0386 the glutamine–
asparagine pair is likely to make contacts with the nucleotide
and therefore regulate nucleotide binding. Mutation of the
asparagine (the side chain of which has hydrogen bond accept-
ing and donating groups) to a serine (competent only to donate
a hydrogen bond) resulted in an enzyme with an apparently in-
creased ATP selectivity, as the guanylyl cyclase activity in the
mutant protein was not detectable [16]. A novel mechanism for
substrate selectivity, by amide bonding-mode switch was there-
fore suggested involving a change in the direction of the amide
oxygen (hydrogen bond acceptor) and the NH2 group (hydro-
gen bond donor) with respect to the corresponding donor or
acceptor groups in the nucleotide at the active site, e.g. amino
group in ATP versus the keto group in GTP [28].2.7. An adenylyl cyclase from M. avium is a pseudogene in
M. tuberculosis: Rv1120c and Ma1120
The Rv1120c gene was suggested to be a pseudogene in
M. tuberculosis owing to the deletion of a single base that leads
to a frame-shift and premature truncation of the protein [19].
A functional orthologue was identiﬁed in M. avium strain
TN104 (cloned and called Ma1120) and M. avium subsp. par-
atuberculosis (MAP2672) by in silico comparative genomics
[29]. Interestingly, Ma1120 is highly active, despite the natural
substitution of the transition-state stabilizing asparagine by
alanine (A164) in this protein [29], suggesting a lack of require-
ment of this residue in catalysis, much like Rv1900c [14]. In-
deed, amongst the cyclases whose structures have been
elucidated, Ma1120 shares the highest sequence similarity
(50%) with Rv1900c.
Ma1120 was also the ﬁrst mycobacterial adenylyl cyclase
that was shown to be inhibited by P-site compounds [29].
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had an IC50  50 lM against Ma1120, however, 2 0,5 0-dideoxy-
adenosine-3 0-triphosphate, with extra phosphate groups on the
3 0-hydroxyl group of ribose, was found to be more potent
(IC50  750 nM) [29]. This is similar to the observations with
mammalian adenylyl cyclases where multiple phosphate
groups on the 3 0-hydroxyl position increase the potency of
P-site compounds [21].
2.8. Uncharacterized enzymes: Rv0891c, Rv1358, Rv1359,
Rv2212, Rv2435c, Rv2488c
Rv0891c, a protein of 285 amino acids and containing only a
cyclase domain, is related to the DNA-binding domain con-
taining cyclases (Table 1; 60–70% similarity to the cyclase
domains of Rv0386, Rv2488c and Rv1358) in M. tuberculosis
[19]. Puriﬁed Rv0891c has detectable adenylyl cyclase activity
(unpublished observations), and Rv1358, Rv1359 and
Rv2488c though related to Rv0386, need to be biochemically
characterized. As seen in Fig. 2, Rv1358 (lacking the second
metal-binding aspartate and transition stabilizing arginine),
Rv1359 (lacking the ﬁrst metal-binding aspartate and transi-
tion state stabilizing arginine) and Rv2488c (lacking the tran-
sition state stabilizing asparagine) cyclase domains may have
undergone several structural changes if they are indeed found
to be active [19]. However, an allosteric function for the cyclaseFig. 4. Phylogenetic analysis and domain compositions of mycobacterial ad
cyclase domains (generated with the MUSCLE programme) was drawn usin
[45]). A condensed tree topology, retaining only those branches with >50% su
in diﬀerent colours to bring out the close clustering of proteins with similar ov
pink and purple, proteins with cyclase domains only; dark blue, cyclase, ATPa
domain only; green, six transmembrane regions and a cyclase domain; grey, f
brown, two transmembrane regions, HAMP and cyclase domains; yellow, ab
black, cyclase with the YSH domain.domains, in regulating the putative DNA-binding activity of
these proteins, is also an attractive and testable hypothesis.
Rv2212 is similar to Rv1264 (43% similarity across full
length proteins; Table 1) and also cyclases from Thermobi-
ﬁda and Nocardia. Since this protein has all residues re-
quired for catalysis it will probably be an active adenylyl
cyclase.
Rv2435c is an interesting variant having two predicted trans-
membrane regions followed by the HAMP domain and a
cyclase domain (Table 1), with the substitution of the ﬁrst
metal-binding residue by asparagine, both transition-state sta-
bilizing residues by non-canonical residues (serine–glutamine;
Fig. 2), and the presence of an arginine in place of the ﬁrst
substrate specifying lysine. Interestingly, the catalytic domain
of Rv2435c is 55% similar to that of Rv1625c, but diﬀers
at almost all critical sites (Fig. 2).3. Bioinformatic analysis of adenylyl cyclases in recently
sequenced mycobacterial genomes
The diversity in biochemical and structural features of the
mycobacterial enzymes is readily apparent from the previous
summary. Given the potential wealth of information that is
likely to be gained from further studies on these mycobacterialenylyl cyclases. A neighbour-joining tree based on an alignment of the
g the Molecular Evolutionary Genetic Analysis package (version 3.1,
pport in a 1000 trial interior-branch test, is shown. Branches are shown
erall domain composition (see Table 1 for domain compositions). Red,
se and DNA binding domains; cyan and lighter shades of blue, ATPase
our, six or seven transmembrane regions, HAMP and cyclase domains;
-hydrolase and cyclase domain orange, cyclase with a receiver domain;
A.R. Shenoy, S.S. Visweswariah / FEBS Letters 580 (2006) 3344–3352 3351cyclases, we identiﬁed all class III cyclases from mycobacteria
whose genomes have been completely sequenced, which in-
cludes M. bovis, M. leprae, M. avium subsp. paratuberculosis,
M. smegmatis and M. marinum (Table 1). We found that
mycobacteria such asM. marinum,M. avium, andM. smegma-
tis also encode up to 10 or more cyclases (Table 1). TheM. lep-
rae genome, despite its general gene-loss, has retained 4
functional nucleotide cyclases (Table 1). Most strikingly, M.
marinum, whose genome has been recently sequenced at the
Wellcome Trust Sanger Institute, shows the presence of 31
class III cyclases (Table 1). A phylogenetic clustering of cyc-
lases, based only on the class III cyclase domain in these pro-
teins, shows an interesting diversity of adenylyl cyclases in this
group of bacteria (Fig. 4). By comparing the domain composi-
tions of cyclases in Table 1, with the phylogenetic tree shown
in Fig. 4, orthologous cyclases, expectedly, are present within
the same cluster. Interestingly, no putative-DNA-binding do-
main containing cyclases are found in M. smegmatis. This is
in agreement with the fact that based on a 16s rRNA phylog-
eny, the slow growing mycobacteria are more closely related
among themselves than with the fast growing M. smegmatis
[30]. Notice the presence of DNA-binding domain containing
cyclases within a single cluster (Fig. 4). Further, the ATPase-
cyclase cyclases (e.g. ML2341 and MM5242) are in a cluster
distinct from the cyclase-ATPase protein (MAP3844) suggest-
ing independent origins of these domain combinations from
diﬀerent parental cyclase domains (Fig. 4).
It is worth noting that M. marinum contains cyclases that
have no equivalents in other mycobacteria, such as the cyclase
with a two-component receiver, and the cyclase with a YSH
domain (Table 1). Additionally, M. avium also contains un-
ique cyclases, in particular the very large (>3000 amino acids)
cyclase with transcription-regulatory domains (MAP2079).
Switching of the order of domains in the polypeptide chain
provide insights into the versatility of interactions between
the two domains [31,32]. Such a case is seen with the M.
avium (MAP3844) protein. The MAP3844 protein has a ATP-
ase domain followed by a cyclase domain, in contrast to the
cyclase-ATPase domain ordering in ML2341 from M. leprae
(Table 1).4. cAMP in the biology of mycobacteria
The role of cAMP in the biology of mycobacteria is only
poorly understood despite early reports on the presence of
cAMP in pathogenic and non-pathogenic mycobacteria [33].
Cyclic AMP was suggested to assist in preventing M. microti
phago-lysosomal fusion and therefore could be a virulence fac-
tor that subverts the host response [34]. Mycobacteria contain
several cAMP-binding domain containing proteins [35], as well
as a cAMP phosphodiesterase (Rv0805), pointing to the pres-
ence of several proteins that make a complete cAMP signalling
system [36]. A homologue of the cAMP-receptor protein
(CRP) from M. tuberculosis (Rv3676), the most well studied
cAMP-dependent transcription factor, has also been recently
studied [37]. Deletion of Rv3676 leads to attenuation of M.
tuberculosis in macrophage infections and in the mouse model
of tuberculosis, suggesting that several important genes are un-
der cAMP regulation in M. tuberculosis [37]. Further, inacti-
vating point mutations within the cAMP or DNA-binding
domains of Rv3676 were found in several strains of M. bovisBCG and this apparent lack of Rv3676 function was suggested
to be one of the additional reasons for attenuation of these
BCG strains [38]. The identiﬁcation of the mycobacterial
CRP DNA recognition motif will now allow an analysis of
the genomes of various mycobacteria to identify putative
cAMP-responsive genes [39,40]. Cyclic AMP-mediated gene
regulation has already been demonstrated in M. smegmatis
[41,42].
A knock-out strain of M. tuberculosis lacking Rv1625c was
as virulent as the wild-type strain in the mouse model of tuber-
culosis infection [43]. This may not be entirely unexpected gi-
ven the presence of a large number of adenylyl cyclases in
M. tuberculosis, and a knock-out of a single adenylyl cyclase
may not be able to inﬂuence the gross levels of cAMP dramat-
ically. However, a dismissal of the role of adenylyl cyclases in
the biology of mycobacteria based on this ﬁrst observation is
certainly premature.5. Conclusions
Nucleotide cyclases in mycobacteria thus appear to have
just one common property amongst them – that of having re-
tained the basic mechanism of catalytic conversion which re-
quires metal-binding residues contributed by one subunit, and
substrate binding and transition state stabilization contrib-
uted by the second subunit of the dimer. The conservation
of bicarbonate responsiveness is a feature that a few of the
mycobacterial enzymes share with other bacterial and eukary-
otic enzymes. The versatility of the mycobacterial enzymes
and novel domain fusions must allow them to function in
several as well as speciﬁc physiological processes. It is antic-
ipated that continuous eﬀorts in understanding the function
and role of these nucleotide cyclase genes will provide new
and critical information on the biology and pathobiology of
these bacteria.
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